Serkan Fazlı Çelik1, Cemşit Karakurt2, Yılmaz Tabel3, Taner Elmas3, Saim Yoloğlu4. 1. Faculty of Medicine, Department of Pediatric Cardiology, Adnan Menderes University, Aydın, Turkey. docser2003@yahoo.com. 2. Faculty of Medicine, Department of Pediatric Cardiology, Inonu University, Malatya, Turkey. 3. Faculty of Medicine, Department of Pediatric Nephrology, Inonu University, Malatya, Turkey. 4. Faculty of Medicine, Department of Biostatistics, Inonu University, Malatya, Turkey.
Abstract
BACKGROUND: There is no detailed strain analysis of cardiac functions in treated hypertensive pediatric patients. The aim of this study was to evaluate the cardio-protective effects of different drug classes in treated pediatric hypertensive patients. METHODS: Sixty non-obese-treated hypertensive patients with preserved left ventricular (LV) systolic function and 45 age-, sex-, and body mass index-matched healthy subjects underwent clinical evaluation, including 24-h ambulatory blood pressure monitoring, standard echocardiographic examination, tissue Doppler imaging, and two-dimensional Speckle Tracking Echocardiography. The patients were divided into two subgroups based on the effects of the drugs on the Renin Angiotensin Aldosterone System. The subgroup hypertension (HT) 1 received angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and HT 2 subgroup received calcium channel blocker, β-blocker, or diuretics. RESULTS: There was no difference between the two groups and subgroups with respect to clinical, demographic, ABPM, ventricular volumes, ejection fraction, and tissue Doppler imaging (TDI) parameters. For patients and controls, respectively, global longitudinal strain was - 18.70 ± 3.41 versus - 21.01 ± 3.82 (P < 0.001), and global radial strain was 40.6 ± 9.8 versus 54.8 ± 12.8 (P = 0.004). Peak LV twist and peak LV torsion were not significantly different. The patient subgroup analyses with each other revealed no difference in systolic and diastolic myocardial deformation properties. CONCLUSIONS: Strain parameters were reduced in all treated hypertensive children compared to normotensive children, and the various cardiac mechanic parameters were similarly abnormal no matter what type of antihypertensive agent was used.
BACKGROUND: There is no detailed strain analysis of cardiac functions in treated hypertensive pediatric patients. The aim of this study was to evaluate the cardio-protective effects of different drug classes in treated pediatric hypertensivepatients. METHODS: Sixty non-obese-treated hypertensivepatients with preserved left ventricular (LV) systolic function and 45 age-, sex-, and body mass index-matched healthy subjects underwent clinical evaluation, including 24-h ambulatory blood pressure monitoring, standard echocardiographic examination, tissue Doppler imaging, and two-dimensional Speckle Tracking Echocardiography. The patients were divided into two subgroups based on the effects of the drugs on the Renin Angiotensin Aldosterone System. The subgroup hypertension (HT) 1 received angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and HT 2 subgroup received calcium channel blocker, β-blocker, or diuretics. RESULTS: There was no difference between the two groups and subgroups with respect to clinical, demographic, ABPM, ventricular volumes, ejection fraction, and tissue Doppler imaging (TDI) parameters. For patients and controls, respectively, global longitudinal strain was - 18.70 ± 3.41 versus - 21.01 ± 3.82 (P < 0.001), and global radial strain was 40.6 ± 9.8 versus 54.8 ± 12.8 (P = 0.004). Peak LV twist and peak LV torsion were not significantly different. The patient subgroup analyses with each other revealed no difference in systolic and diastolic myocardial deformation properties. CONCLUSIONS: Strain parameters were reduced in all treated hypertensivechildren compared to normotensive children, and the various cardiac mechanic parameters were similarly abnormal no matter what type of antihypertensive agent was used.
Entities:
Keywords:
Antihypertensive drugs; Child; Hypertension; Strain; Systolic function
Authors: E D Frohlich; C Apstein; A V Chobanian; R B Devereux; H P Dustan; V Dzau; F Fauad-Tarazi; M J Horan; M Marcus; B Massie Journal: N Engl J Med Date: 1992-10-01 Impact factor: 91.245
Authors: Ngozi C Agu; Karen McNiece Redwine; Cynthia Bell; Kathleen Marie Garcia; David S Martin; Tim S Poffenbarger; John T Bricker; Ronald J Portman; Monesha Gupta-Malhotra Journal: J Am Soc Hypertens Date: 2014-02-24
Authors: Justyna Zamojska; Katarzyna Niewiadomska-Jarosik; Agnieszka Wosiak; Piotr Lipiec; Jerzy Stańczyk Journal: Kardiol Pol Date: 2014-10-09 Impact factor: 3.108
Authors: Andrew H Tran; Joseph T Flynn; Richard C Becker; Stephen R Daniels; Bonita E Falkner; Michael Ferguson; Coral D Hanevold; Stephen R Hooper; Julie R Ingelfinger; Marc B Lande; Lisa J Martin; Kevin Meyers; Mark Mitsnefes; Bernard Rosner; Joshua A Samuels; Elaine M Urbina Journal: Hypertension Date: 2020-05-04 Impact factor: 10.190
Authors: Shasha Yu; Kai Jiang; Xiang Y Zhu; Christopher M Ferguson; James D Krier; Amir Lerman; Lilach O Lerman Journal: J Hypertens Date: 2021-03-01 Impact factor: 4.844